ARCH Venture Management, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$299.1B
Holdings
11
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BEAMBEAM THERAPEUTICS INC. | 4,540,132 | $77.2B | 25.82% | |
| 2 | VIRVIR BIOTECHNOLOGY INC. | 12,916,663 | $65.1B | 21.76% | |
| 3 | MAZEMAZE THERAPEUTICS INC. | 4,120,053 | $50.6B | 16.91% | |
| 4 | RAPPRAPPORT THERAPEUTICS INC. | 3,728,738 | $42.4B | 14.19% | |
| 5 | VERVVERVE THERAPEUTICS INC. | 2,008,809 | $22.6B | 7.54% | |
| 6 | LYELLYELL IMMUNOPHARMA INC. | 1,820,634 | $16.1B | 5.39% | |
| 7 | ERASERASCA INC. | 11,055,554 | $14.1B | 4.71% | |
| 8 | GOSSGOSSAMER BIO INC. | 8,055,916 | $9.9B | 3.31% | |
| 9 | QTTBQ32 BIO INC. | 320,482 | $477.5M | 0.16% | |
| 10 | UNBXUNITY BIOTECHNOLOGY INC. | 1,004,817 | $385.9M | 0.13% | |
| 11 | CEROCERO THERAPEUTICS HOLDINGS INC. | 22,389 | $215.6M | 0.07% |